032566784	032566784	CD	B-NP	O
|	|	NN	I-NP	O
OC	OC	NN	I-NP	O
|	|	NN	I-NP	O
32147963	32147963	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8348149	8348149	CD	B-NP	O
|	|	CC	I-NP	O
8/24/2007	8/24/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Abdominal	Abdominal	JJ	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
hereditary	hereditary	JJ	B-NP	O
angioedema	angioedema	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/3/2007	9/3/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/6/2007	2/6/2007	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
WILER	WILER	NN	B-NP	O
,	,	,	O	O
FORREST	FORREST	NN	B-NP	O
X	X	SYM	B-NP	O
882-12-27-0	882-12-27-0	CD	I-NP	O
Anre	Anre	NNP	I-NP	O
,	,	,	I-NP	O
Kentucky	Kentucky	NNP	I-NP	O
93770	93770	CD	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
2/25/07	2/25/07	CD	B-NP	O
AT	AT	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
NORDEN	NORDEN	NNP	B-NP	O
,	,	,	O	O
OLIVER	OLIVER	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

ACETYLSALICYLIC	ACETYLSALICYLIC	NNP	B-NP	O
ACID	ACID	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CHILDREN	CHILDREN	NNP	I-NP	O
'S	'S	POS	B-NP	O
-RRB-	-RRB-	JJ	I-NP	O
81	81	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

DIGOXIN	DIGOXIN	NN	B-NP	O
0.125	0.125	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
4X/WEEK	4X/WEEK	NN	I-NP	O
TUES/THU/SAT	TUES/THU/SAT	NN	I-NP	O
/	/	SYM	B-VP	O
SUN	SUN	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

DIGOXIN	DIGOXIN	NN	B-NP	O
0.187	0.187	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
3X/WEEK	3X/WEEK	NN	I-NP	O
M-W-F	M-W-F	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

DOCUSATE	DOCUSATE	JJ	B-NP	O
SODIUM	SODIUM	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

FEXOFENADINE	FEXOFENADINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
60	60	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	B-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

LEVOTHYROXINE	LEVOTHYROXINE	NN	B-NP	B-protein
SODIUM	SODIUM	NN	I-NP	I-protein
50	50	CD	I-NP	I-protein
MCG	MCG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

SENNOSIDES	SENNOSIDES	NNS	B-NP	O
2	2	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	B-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

STANAZOLOL	STANAZOLOL	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QOD	QOD	NN	I-NP	I-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

STANAZOLOL	STANAZOLOL	NN	B-NP	O
1	1	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QOD	QOD	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

ATENOLOL	ATENOLOL	NN	B-NP	O
100	100	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

FUROSEMIDE	FUROSEMIDE	NN	B-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
1-3	1-3	NN	I-NP	O
TABS	TABS	NNP	I-NP	O
QD	QD	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNP	I-NP	O
ON	ON	NNP	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
ATENOLOL	ATENOLOL	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
0.187	0.187	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
3x/Week	3x/Week	NNP	I-NP	O
M-W-F	M-W-F	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ON	ON	NNP	I-NP	O
FRIDAY	FRIDAY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/25/07	2/25/07	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
dose	dose	NN	I-NP	O
Previous	Previous	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/29/07	8/29/07	CD	B-NP	O
by	by	IN	B-PP	O
GOYETTE	GOYETTE	NNP	B-NP	O
,	,	,	O	O
MICHEL	MICHEL	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
SYNTHROID	SYNTHROID	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
256699854	256699854	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DIGOXIN	DIGOXIN	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
DIGOXIN	DIGOXIN	NN	I-NP	O
0.125	0.125	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
4x/weekTuThSaSun	4x/weekTuThSaSun	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/25/07	2/25/07	CD	B-NP	O
by	by	IN	B-PP	O
CARACCI	CARACCI	NNP	B-NP	O
,	,	,	O	O
LAVERN	LAVERN	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
med	me	VBD	B-VP	O
COLACE	COLACE	NN	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
ALLEGRA	ALLEGRA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FEXOFENADINE	FEXOFENADINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
60	60	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
November	November	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Other	Other	NNP	I-NP	O
:	:	:	O	O
allergy	allergy	NNP	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

LASIX	LASIX	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
August	August	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/29/07	8/29/07	CD	B-NP	O
by	by	IN	B-PP	O
REISTAD	REISTAD	NNP	B-NP	O
,	,	,	O	O
IVAN	IVAN	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LASIX	LASIX	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
998347507	998347507	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Sulfa	Sulfa	NNP	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
RASH	RASH	NN	B-NP	B-protein
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
regimen	regimen	NN	I-NP	O
SYNTHROID	SYNTHROID	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
50	50	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/25/07	2/25/07	CD	B-NP	O
by	by	IN	B-PP	O
FELLON	FELLON	NNP	B-NP	O
,	,	,	O	O
RUSSEL	RUSSEL	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
DIGOXIN	DIGOXIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
423040245	423040245	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
med	me	VBD	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/25/07	2/25/07	CD	B-NP	O
by	by	IN	B-PP	O
MAZZUCA	MAZZUCA	NNP	B-NP	O
,	,	,	O	O
FREDDY	FREDDY	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
DIGOXIN	DIGOXIN	NN	B-NP	O
PO	PO	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
3x/Week	3x/Week	NN	I-NP	O
M-W-F	M-W-F	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
376107332	376107332	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
dose	dose	NN	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/29/07	8/29/07	CD	B-NP	O
by	by	IN	B-PP	O
HUISINGA	HUISINGA	NNP	B-NP	O
,	,	,	O	O
ADOLPH	ADOLPH	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DIGOXIN	DIGOXIN	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
SENNA	SENNA	NN	I-NP	O
TABLETS	TABLETS	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
SENNOSIDES	SENNOSIDES	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
2	2	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
STANOZOLOL	STANOZOLOL	NN	I-NP	O
2	2	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q6H	Q6H	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
October	October	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Lorin	Lorin	NNP	I-NP	O
Friday	Friday	NNP	B-NP	O
,	,	,	O	O
August	August	NNP	B-NP	O
rd	rd	NN	I-NP	O
,	,	,	O	O
11am	11am	NN	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Sandersen	Sandersen	NNP	I-NP	O
Please	Please	NNP	I-NP	O
call	call	NN	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
at	at	IN	B-PP	O
your	your	PRP$	B-NP	O
convenience	convenience	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
2-3	2-3	CD	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
or	or	CC	O	O
earlier	earlier	RBR	B-ADVP	O
if	if	IN	B-SBAR	O
needed	need	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
IV	IV	CD	B-NP	O
Contrast	Contrast	NN	I-NP	O
,	,	,	O	O
Sulfa	Sulfa	NNP	B-NP	O
,	,	,	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
QUINIDINE	QUINIDINE	NNP	B-NP	O
SULFATE	SULFATE	NNP	I-NP	O
,	,	,	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
,	,	,	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
,	,	,	O	O
NITROFURANTOIN	NITROFURANTOIN	NNP	B-NP	O
,	,	,	O	O
PROCAINE	PROCAINE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
,	,	,	O	O
Dairy	Dairy	NNP	B-NP	O
Products	Products	NNP	I-NP	O
,	,	,	O	O
WHEAT/GLUTEN	WHEAT/GLUTEN	NNP	B-NP	O
,	,	,	O	O
NITROFURANTOIN	NITROFURANTOIN	NNP	B-NP	O
MACROCRYSTAL	MACROCRYSTAL	NNP	I-NP	O
,	,	,	O	O
FFP	FFP	NNP	B-NP	O
,	,	,	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Abdominal	Abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
hereditary	hereditary	JJ	B-NP	O
angioedema	angioedema	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Abdominal	Abdominal	NNP	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
hereditary	hereditary	JJ	B-NP	O
angioedema	angioedema	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HEREDITARY	HEREDITARY	NNP	I-NP	O
ANGIOEDEMA	ANGIOEDEMA	NNP	I-NP	O
H/O	H/O	NNP	I-NP	O
SUBDURAL	SUBDURAL	NNP	I-NP	O
ON	ON	NNP	I-NP	O
COUM	COUM	NNP	I-NP	O
S/P	S/P	NNP	I-NP	O
APPY	APPY	NNP	I-NP	O
,	,	,	O	O
TAH	TAH	NN	B-NP	B-protein
tracheostomies	tracheostomy	NNS	I-NP	I-protein
x	x	SYM	O	I-protein
3	3	CD	B-NP	I-protein
multiple	multiple	JJ	I-NP	O
intubations	intubation	NNS	I-NP	O
DVT	DVT	NN	I-NP	O
,	,	,	O	O
ivc	ivc	NN	B-NP	O
filter	filter	NN	I-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	B-protein
GERD	GERD	NN	I-NP	I-protein
polycythemia	polycythemia	NN	I-NP	I-protein
AFib	AFib	NN	I-NP	I-protein
-	-	HYPH	B-VP	O
no	no	DT	B-NP	O
coumadin	coumadin	NN	I-NP	B-protein
2/2	2/2	CD	I-NP	I-protein
SDH	SDH	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
44	44	CD	I-NP	I-protein
-RRB-	-RRB-	SYM	I-NP	I-protein
hypothyroidism	hypothyroidism	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hypothyroidism	hypothyroidism	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
GIB	GIB	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	O	O
lower	low	JJR	B-NP	O
GI	GI	NN	I-NP	O
bleeding	bleed	VBG	B-VP	O
-RRB-	-RRB-	HYPH	B-NP	O
DM	DM	NN	I-NP	O
-	-	HYPH	B-NP	O
diet	diet	NN	I-NP	O
controlled	control	VBN	B-VP	O
-LRB-	-LRB-	NN	B-NP	O
borderline	borderline	JJ	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CAD	CAD	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
NONE	NONE	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Transfusion	Transfusion	NNP	I-NP	O
:	:	:	O	O
FFP	FFP	NN	B-NP	B-protein
x	x	CC	O	I-protein
4	4	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
Dose	Dose	VBP	B-VP	O
adjustment	adjustment	NN	B-NP	O
of	of	IN	B-PP	O
Stanozolol	Stanozolol	NN	B-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
PCP	PCP	NN	B-NP	O
:	:	:	O	O
Grady	Grady	NNP	B-NP	O
Knickelbein	Knickelbein	NNP	I-NP	O
,	,	,	O	O
Inpatient	Inpatient	NNP	B-NP	O
attg	attg	NN	I-NP	O
:	:	:	O	O
Archie	Archie	NNP	B-NP	O
Derosso	Derosso	NNP	I-NP	O
,	,	,	O	O
Allergy/Immunology	Allergy/Immunology	NNP	B-NP	O
Attg	Attg	NNP	I-NP	O
:	:	:	O	O
Morello	Morello	NNP	B-NP	O
Primary	Primary	NNP	I-NP	O
Immunologist	Immunologist	NNP	I-NP	O
:	:	:	O	O
Federico	Federico	NNP	B-NP	O
Kotch	Kotch	NNP	I-NP	O
ENT	ENT	NNP	I-NP	O
:	:	:	O	O
Krysinski	Krysinski	NNP	B-NP	O
.	.	.	O	O

RFA	RFA	NN	B-NP	B-protein
:	:	:	O	O
Hereditary	Hereditary	JJ	B-NP	O
angioedema	angioedema	NN	I-NP	O
abdominal	abdominal	JJ	I-NP	O
flare	flare	NN	I-NP	O
.	.	.	O	O

CC	CC	NN	B-NP	O
:	:	:	O	O
Abdominal	Abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

HPI	HPI	LS	B-LST	B-cell_type
:	:	:	O	O
83	83	CD	B-NP	O
F	F	NN	I-NP	O
with	with	IN	B-PP	O
hereditary	hereditary	JJ	B-NP	B-protein
angio-edema	angio-edema	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
C1-esterase	C1-esterase	NN	I-NP	I-protein
inhibitor	inhibitor	NN	I-NP	O
deficiency	deficiency	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	O	O
multiple	multiple	JJ	B-NP	O
prior	prior	JJ	I-NP	O
attacks	attack	NNS	I-NP	O
characterized	characterize	VBN	B-VP	O
by	by	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
distension	distension	NN	I-NP	O
and	and	CC	I-NP	O
airway	airway	NN	I-NP	O
compromise	compromise	NN	I-NP	O
s/p	s/p	NN	I-NP	O
tracheostomy	tracheostomy	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
USOH	USOH	NN	I-NP	B-protein
until	until	IN	B-PP	O
this	this	DT	B-NP	O
morning	morning	NN	I-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
worsening	worsen	VBG	I-VP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
periumbilical	periumbilical	JJ	B-NP	O
,	,	,	I-NP	O
constant	constant	JJ	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
distension	distension	NN	I-NP	O
and	and	CC	O	O
typical	typical	JJ	B-ADJP	O
of	of	IN	B-PP	O
prior	prior	JJ	B-NP	O
attacks	attack	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
new	new	JJ	I-NP	O
foods	food	NNS	I-NP	O
-	-	HYPH	B-VP	O
typically	typically	RB	B-ADVP	O
these	these	DT	B-NP	O
episodes	episode	NNS	I-NP	O
are	be	VBP	B-VP	O
without	without	IN	B-PP	O
an	an	DT	B-NP	O
identifiable	identifiable	JJ	I-NP	O
precipitant	precipitant	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
associated	associate	VBN	I-NP	O
nausea/vomiting	nausea/vomiting	NN	I-NP	O
or	or	CC	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
.	.	.	O	O

+	+	SYM	B-NP	O
flatus	flatus	NN	I-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
bowel	bowel	NN	B-NP	O
movement	movement	NN	I-NP	O
this	this	DT	B-NP	O
AM	AM	NN	I-NP	O
.	.	.	O	O

Typical	Typical	JJ	B-NP	O
BM	BM	NN	I-NP	O
's	's	POS	B-NP	O
are	be	VBP	B-VP	O
either	either	CC	O	O
watery	watery	NN	B-NP	O
or	or	CC	O	O
``	``	``	O	O
pencil	pencil	NN	B-NP	O
thin	thin	JJ	I-NP	O
''	''	''	O	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
colonic	colonic	JJ	B-NP	O
stricture	stricture	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
multiple	multiple	JJ	I-NP	O
dilatations	dilatation	NNS	I-NP	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

No	No	DT	B-NP	O
respiratory	respiratory	JJ	I-NP	O
distress	distress	NN	I-NP	O
,	,	,	I-NP	O
rash	rash	NN	I-NP	O
or	or	CC	I-NP	O
hives	hive	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
called	call	VBD	B-VP	O
her	her	PRP$	B-NP	O
Allergist/Immunologist	Allergist/Immunologist	NN	I-NP	O
who	who	WP	B-NP	O
advised	advise	VBD	B-VP	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
take	take	VB	I-VP	O
2mg	2mg	NN	B-NP	B-protein
Stanozolol	Stanozolol	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
instead	instead	RB	B-CONJP	O
of	of	IN	I-CONJP	O
1mg	1mg	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	O	O
come	come	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NNP	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
attacks	attack	NNS	I-NP	O
have	have	VBP	B-VP	O
responded	respond	VBN	I-VP	O
to	to	TO	B-PP	O
FFP	FFP	NN	B-NP	B-protein
.	.	.	O	O

Yet	Yet	RB	B-ADVP	O
,	,	,	O	O
given	give	VBN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hives	hive	NNS	B-NP	O
to	to	TO	B-PP	O
FFP	FFP	NN	B-NP	B-protein
,	,	,	O	O
she	she	PRP	B-NP	O
requires	require	VBZ	B-VP	O
premedication	premedication	NN	B-NP	O
with	with	IN	B-PP	O
Benadryl	Benadryl	NN	B-NP	O
.	.	.	O	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
,	,	,	O	O
vitals	vital	NNS	B-NP	O
were	be	VBD	B-VP	O
T99	T99	NN	B-NP	O
.9	.9	NN	I-NP	O
,	,	,	O	O
BP138/80	BP138/80	NN	B-NP	B-protein
,	,	,	O	O
HR	HR	NN	B-NP	B-protein
69	69	CD	I-NP	I-protein
,	,	,	O	O
RR16	RR16	NN	B-NP	B-protein
,	,	,	O	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
ED	ED	VBD	B-VP	O
staff	staff	NN	B-NP	O
discussed	discuss	VBD	B-VP	O
case	case	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Fellin	Fellin	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Immunology	Immunology	NNP	I-NP	O
Fellow	Fellow	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
and	and	CC	O	O
treatment	treatment	NN	B-NP	O
initiated	initiate	VBD	B-VP	O
:	:	:	O	O
Benadryl	Benadryl	NN	B-NP	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
x	x	NN	I-NP	O
1	1	CD	B-NP	O
,	,	,	O	O
albuerol	albuerol	NN	B-NP	O
neb	neb	NN	I-NP	O
x	x	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
duoneb	duoneb	NN	B-NP	O
x	x	NN	I-NP	O
1	1	CD	I-NP	O
.	.	.	O	O

Stanozolol	Stanozolol	NN	B-NP	O
2mg	2mg	NN	I-NP	O
PO	PO	NN	I-NP	O
x	x	SYM	B-NP	O
1	1	CD	I-NP	O
.	.	.	O	O
.	.	.	O	O

ROS	ROS	NN	B-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
recent	recent	JJ	I-NP	O
fevers/chills	fevers/chill	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
cough/sob	cough/sob	NN	I-NP	O
.	.	.	O	O

Intermittently	Intermittently	RB	B-NP	O
suctions	suction	NNS	I-NP	O
tracheostomy	tracheostomy	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
recent	recent	JJ	I-NP	O
problems	problem	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
chest	chest	NN	I-NP	O
pain/palpitations	pain/palpitation	NNS	I-NP	O
.	.	.	O	O
.	.	.	O	O

PMH	PMH	NN	B-NP	B-protein
:	:	:	O	I-protein
1	1	LS	B-LST	I-protein
.	.	.	O	O

Hereditary	Hereditary	JJ	B-NP	O
angioedema	angioedema	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
tracheostomies	tracheostomy	NNS	I-NP	O
for	for	IN	B-PP	O
airway	airway	NN	B-NP	O
protection	protection	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

DVT	DVT	NN	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
IVC	IVC	NN	I-NP	O
filter	filter	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Recurrent	Recurrent	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
:	:	:	O	O
rate	rate	NN	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
coumadin	coumadin	NN	I-NP	B-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

H/o	H/o	NN	B-NP	O
subdural	subdural	JJ	I-NP	O
hematoma	hematoma	NN	I-NP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
fall	fall	NN	I-NP	O
in	in	IN	B-PP	O
1992	1992	CD	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	B-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

Moderate	Moderate	NNP	B-NP	O
MR.	MR.	NNP	I-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

Gastroesophageal	Gastroesophageal	JJ	B-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Diabetes	Diabete	NNS	B-NP	O
:	:	:	O	O
diet	diet	NN	B-NP	O
controlled	control	VBN	B-VP	O
.	.	.	O	O

Last	Last	JJ	B-NP	O
A1C	A1C	NN	I-NP	O
in	in	IN	B-PP	O
2006	2006	CD	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Hypothyroidism	Hypothyroidism	NN	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

CAD	CAD	NN	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Ejection	Ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
2003	2003	CD	B-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
colectomy	colectomy	NN	I-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
hysterectomy	hysterectomy	NN	I-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
carpal	carpal	JJ	B-NP	O
tunnel	tunnel	NN	I-NP	O
release	release	NN	I-NP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
left	leave	VBD	B-VP	O
cataract	cataract	NN	B-NP	O
repair	repair	NN	I-NP	O
.	.	.	O	O

17	17	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
sigmoid	sigmoid	JJ	B-NP	O
colostomy	colostomy	NN	I-NP	O
and	and	CC	I-NP	O
reanastomosis	reanastomosis	NN	I-NP	O
ten	ten	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
stricture	stricture	NN	B-NP	O
18	18	CD	I-NP	O
.	.	.	O	O

S/p	S/p	NN	B-NP	O
multiple	multiple	JJ	I-NP	O
dilations	dilation	NNS	I-NP	O
of	of	IN	B-PP	O
colonic	colonic	JJ	B-NP	O
stricture	stricture	NN	I-NP	O
.	.	.	O	O

19	19	CD	B-NP	O
.	.	.	O	O

Sensorineural	Sensorineural	JJ	B-NP	O
hearing	hearing	NN	I-NP	O
loss	loss	NN	I-NP	O
,	,	,	O	O
bilateral	bilateral	JJ	B-ADJP	O
.	.	.	O	O

19	19	CD	B-NP	O
.	.	.	O	O

Diverticulosis	Diverticulosis	NNP	B-NP	O
MEDS	MEDS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Allegra	Allegra	DT	B-NP	O
60	60	CD	I-NP	O
BID	BID	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Atenolol	Atenolol	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
QAM	QAM	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Lasix	Lasix	RB	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
daily	daily	RB	B-ADVP	O
4	4	CD	B-NP	O
.	.	.	O	O

Digoxin	Digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
QOD	QOD	NN	I-NP	O
MWF	MWF	NN	I-NP	O
.	.	.	O	O

0.180	0.180	CD	B-NP	O
on	on	IN	B-PP	O
other	other	JJ	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Rhinocort	Rhinocort	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
spray	spray	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

Stanozolol	Stanozolol	NN	B-NP	O
alternating	alternate	VBG	B-VP	O
1mg	1mg	NN	B-NP	O
QD/2mg	QD/2mg	NN	I-NP	O
QD	QD	NN	I-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

Synthroid	Synthroid	JJ	B-NP	O
50	50	CD	I-NP	O
mcg	mcg	NN	I-NP	O
daily	daily	JJ	I-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

colace	colace	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
BID	BID	NN	I-NP	B-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

Senna	Senna	NNP	B-NP	O
1	1	CD	I-NP	O
tab	tab	NN	I-NP	O
BID	BID	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Zantac	Zantac	NN	B-NP	B-protein
150	150	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
11	11	CD	I-NP	I-protein
.	.	.	O	O

ECASA	ECASA	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

ALL	ALL	NN	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

FFP	FFP	NN	B-NP	B-protein
gives	give	VBZ	B-VP	O
her	her	PRP$	B-NP	O
hives	hive	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
prevented	prevent	VBN	I-VP	O
when	when	WRB	B-ADVP	O
premedicated	premedicate	VBN	B-VP	O
with	with	IN	B-PP	O
Benadryl	Benadryl	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

IV	IV	CD	B-NP	O
contrast	contrast	NN	I-NP	O
gives	give	VBZ	B-VP	O
her	her	PRP$	B-NP	O
rash	rash	NN	I-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
.	.	.	O	O

penicillin	penicillin	IN	B-PP	O
a	a	DT	B-NP	O
rash	rash	NN	I-NP	O
,	,	,	O	O
4	4	CD	B-NP	O
.	.	.	O	O

sulfonamides	sulfonamide	VBZ	B-VP	O
a	a	DT	B-NP	O
rash	rash	NN	I-NP	B-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

Levaquin	Levaquin	IN	B-PP	O
a	a	DT	B-NP	O
rash	rash	NN	I-NP	B-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

stanozolol	stanozolol	NN	B-NP	O
and	and	CC	I-NP	O
nitrofurantoin	nitrofurantoin	NN	I-NP	O
gives	give	VBZ	B-VP	O
elevated	elevate	VBN	B-NP	O
LFTs	LFT	NNS	I-NP	B-protein
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Diet	Diet	NN	B-NP	O
:	:	:	O	O
allergic	allergic	JJ	B-ADJP	O
to	to	TO	B-PP	O
wheat	wheat	NN	B-NP	O
and	and	CC	I-NP	O
eggs/dairy	eggs/dairy	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
flu	flu	NN	I-NP	O
vaccine	vaccine	NN	I-NP	O
2/2	2/2	CD	I-NP	O
egg	egg	NN	I-NP	O
allergy	allergy	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Tolerates	Tolerates	NNP	B-NP	O
Keflex	Keflex	NNP	I-NP	O
.	.	.	O	O
.	.	.	O	O

SH	SH	NN	B-NP	O
:	:	:	O	O
Lives	Life	NNS	B-NP	O
with	with	IN	B-PP	O
elderly	elderly	JJ	B-NP	O
husband	husband	NN	I-NP	O
who	who	WP	B-NP	O
has	have	VBZ	B-VP	O
Alzheimers	Alzheimers	NNP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
caretaker	caretaker	NN	I-NP	O
.	.	.	O	O
.	.	.	O	O

ADMIT	ADMIT	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
VS	VS	NN	B-NP	O
:	:	:	O	O
T	T	NN	B-NP	O
:	:	:	O	O
99.0	99.0	CD	B-NP	O
P	P	NN	I-NP	O
:	:	:	O	O
86	86	CD	B-NP	O
BP	BP	NN	I-NP	O
:	:	:	O	O
138/80	138/80	CD	B-NP	O
RR	RR	NN	I-NP	O
:	:	:	O	O
20	20	CD	B-NP	O
O2	O2	NN	I-NP	O
Sat	Sat	NNP	I-NP	O
:	:	:	O	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
Gen	Gen	NNP	I-NP	O
:	:	:	O	O
Well	Well	NNP	B-NP	O
appearing	appear	VBG	B-VP	O
,	,	,	O	O
trach	trach	NN	B-NP	O
collar	collar	NN	I-NP	O
,	,	,	O	O
fully	fully	RB	B-ADJP	O
alert	alert	JJ	I-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	B-protein
x	x	NN	B-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Moderate	Moderate	JJ	B-NP	O
distress	distress	NN	I-NP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
respiratory	respiratory	JJ	I-NP	O
distress	distress	NN	I-NP	O
HEENT	HEENT	NN	I-NP	O
:	:	:	O	O
EOM	EOM	NN	B-NP	O
full	full	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
facial	facial	JJ	I-NP	O
swelling	swelling	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
Icterus	Icterus	NNP	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
oral	oral	JJ	I-NP	O
lesions/airway	lesions/airway	NN	I-NP	O
swelling	swelling	NN	I-NP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
supple	supple	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
or	or	CC	O	O
thyromegaly	thyromegaly	RB	B-ADVP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
JVP	JVP	NN	B-NP	B-protein
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
6	6	CD	I-NP	O
cm	cm	NN	I-NP	O
water	water	NN	I-NP	O
,	,	,	O	O
irregularly	irregularly	RB	B-ADJP	O
irregular	irregular	JJ	I-ADJP	O
,	,	,	O	O
2/6	2/6	CD	B-NP	O
HSM	HSM	NN	I-NP	O
at	at	IN	B-PP	O
apex	apex	NN	B-NP	O
.	.	.	O	O

Laterally	Laterally	RB	B-NP	O
displaced	displace	VBN	I-NP	O
PMI	PMI	NN	I-NP	O
.	.	.	O	O

CHEST	CHEST	NN	B-NP	O
:	:	:	O	O
bibasilar	bibasilar	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
1/3	1/3	CD	B-NP	O
up	up	IN	B-PRT	O
.	.	.	O	O

No	No	DT	B-NP	O
wheezes	wheeze	VBZ	B-VP	O
or	or	CC	O	O
rhochi	rhochi	NN	B-NP	O
.	.	.	O	O

ABD	ABD	NN	B-NP	O
:	:	:	O	O
BS	BS	NN	B-NP	O
normoactive	normoactive	JJ	B-ADJP	O
.	.	.	O	O

Prominent	Prominent	JJ	B-NP	O
distension	distension	NN	I-NP	O
,	,	,	O	O
tympanic	tympanic	NN	B-NP	O
.	.	.	O	O

Tender	Tender	NN	B-NP	O
mid-abdomen	mid-abdoman	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
rebound/guarding	rebound/guarding	NN	I-NP	O
.	.	.	O	O

EXT	EXT	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

SKIN	SKIN	NN	B-NP	B-protein
:	:	:	O	O
No	No	DT	B-NP	O
rashes	rash	NNS	I-NP	O
,	,	,	O	O
wheals	wheal	NNS	B-NP	O
,	,	,	O	O
hives	hive	VBZ	B-VP	O
.	.	.	O	O

RELEVANT	RELEVANT	NNP	B-NP	O
LABS	LABS	NNP	I-NP	O
:	:	:	O	O
C1	C1	NN	B-NP	B-protein
inh	inh	NN	I-NP	I-protein
9	9	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	I-protein
low	low	JJ	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
On	On	IN	B-PP	O
admit	admit	NN	B-NP	O
:	:	:	O	O
Cr	Cr	NN	B-NP	O
1.2	1.2	CD	I-NP	O
-LRB-	-LRB-	:	O	O
bl	bl	NN	B-NP	O
1.0	1.0	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
BUN21	BUN21	NN	I-NP	O
,	,	,	O	O
HCT	HCT	NN	B-NP	O
59.2	59.2	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
as	as	RB	B-ADJP	O
high	high	JJ	I-ADJP	O
as	as	IN	B-PP	O
HCT	HCT	NN	B-NP	B-DNA
60	60	CD	I-NP	I-DNA
on	on	IN	B-PP	O
9/7	9/7	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
u/a	u/a	NN	I-NP	O
:	:	:	O	O
bland	bland	VB	B-VP	O
Studies	Study	NNS	B-NP	O
:	:	:	O	O
ECG	ECG	NN	B-NP	O
:	:	:	O	O
Afib	Afib	NN	B-NP	O
90	90	CD	I-NP	O
,	,	,	O	O
LAD	LAD	NN	B-NP	O
,	,	,	O	O
LVH	LVH	NN	B-NP	B-protein
CXR	CXR	NN	I-NP	I-protein
:	:	:	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
cardiopulmonary	cardiopulmonary	JJ	I-NP	O
process	process	NN	I-NP	O
KUB	KUB	NN	I-NP	O
:	:	:	O	O
mildly	mildly	RB	B-NP	O
dilated	dilate	VBN	I-NP	O
loops	loop	NNS	I-NP	O
of	of	IN	B-PP	O
bowel	bowel	NN	B-NP	O
.	.	.	O	O

no	no	DT	B-NP	O
obstruction	obstruction	NN	I-NP	O
--	--	:	O	O
Consults	Consult	NNS	B-NP	O
:	:	:	O	O
Followed	Follow	VBN	B-NP	O
in-house	in-house	NN	I-NP	O
by	by	IN	B-PP	O
attg	attg	NN	B-NP	O
Loughman	Loughman	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Allergy/Immuno	Allergy/Immuno	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Impression	Impression	NNP	I-NP	O
:	:	:	O	O
Abdominal	Abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
hereditary	hereditary	JJ	B-NP	O
angioedema	angioedema	NN	I-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
in	in	IN	B-PP	O
nature	nature	NN	B-NP	O
to	to	TO	B-PP	O
prior	prior	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
hereditary	hereditary	JJ	B-NP	O
angioedema	angioedema	NN	I-NP	O
flare	flare	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
ffp	ffp	NN	B-NP	B-protein
x	x	SYM	B-VP	I-protein
2units	2unit	NNS	B-NP	I-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
with	with	IN	B-PP	O
benadryl	benadryl	NN	B-NP	O
premedication	premedication	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
develop	develop	VB	I-VP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
facial	facial	JJ	I-NP	O
hives	hive	NNS	I-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
respiratory	respiratory	JJ	I-NP	O
distress	distress	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
unit	unit	NN	I-NP	O
of	of	IN	B-PP	O
FFP	FFP	NN	B-NP	B-protein
.	.	.	O	O

This	This	DT	B-NP	O
resolved	resolve	VBD	B-VP	O
after	after	IN	B-PP	O
FFP	FFP	NN	B-NP	O
infusion	infusion	NN	I-NP	O
stopped	stop	VBD	B-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
additional	additional	JJ	B-NP	O
benadryl	benadryl	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
benadryl	benadryl	NN	B-NP	O
well	well	RB	B-ADVP	O
,	,	,	O	O
yet	yet	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
sensation	sensation	NN	I-NP	O
of	of	IN	B-PP	O
restlessness	restlessness	NN	B-NP	O
afterwards	afterwards	RB	B-ADVP	O
.	.	.	O	O

On	On	IN	B-PP	O
4/4	4/4	CD	B-NP	O
she	she	PRP	B-NP	O
got	get	VBD	B-VP	O
another	another	DT	B-NP	O
2	2	CD	I-NP	O
units	unit	NNS	I-NP	O
FFP	FFP	NN	I-NP	O
with	with	IN	B-PP	O
premedication	premedication	NN	B-NP	O
of	of	IN	B-PP	O
benadyrl	benadyrl	NN	B-NP	O
25	25	CD	I-NP	O
iv	iv	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
each	each	DT	B-NP	O
bag	bag	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
ativan	ativan	NN	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	RB	B-ADVP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
transfusions	transfusion	NNS	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
good	good	JJ	I-NP	O
combination	combination	NN	I-NP	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
get	get	VB	I-VP	O
hives	hive	NNS	B-NP	O
,	,	,	O	O
nor	nor	CC	O	O
the	the	DT	B-NP	O
anxiety	anxiety	NN	I-NP	O
that	that	WDT	B-NP	O
accompanies	accompany	VBZ	B-VP	O
benadryl	benadryl	NN	B-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
8/21	8/21	CD	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
abdominal	abdominal	JJ	I-NP	O
distension	distension	NN	I-NP	O
had	have	VBD	B-VP	O
improved	improve	VBN	I-VP	O
markedly	markedly	RB	B-ADVP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
had	have	VBD	B-VP	O
largely	largely	RB	B-ADJP	O
subsided	subsided	JJ	I-ADJP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
prior	prior	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
have	have	VBP	B-VP	O
taken	take	VBN	I-VP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
for	for	IN	B-PP	O
complete	complete	JJ	B-NP	O
resolution	resolution	NN	I-NP	O
of	of	IN	B-PP	O
distension	distension	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
instructions	instruction	NNS	B-NP	O
to	to	TO	B-VP	O
contact	contact	VB	I-VP	O
her	her	PRP$	B-NP	O
immunologist	immunologist	NN	I-NP	O
should	should	MD	O	O
symptoms	symptom	NNS	B-NP	O
worsen	worsen	VB	B-VP	O
or	or	CC	I-VP	O
persist	persist	VB	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
stanozolol	stanozolol	NN	I-NP	O
taper	taper	NN	I-NP	O
as	as	IN	B-SBAR	O
outlined	outline	VBN	B-VP	O
by	by	IN	B-PP	O
allergy/immuno	allergy/immuno	NN	B-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
see	see	VB	I-VP	O
patient	patient	NN	B-NP	O
instructions	instruction	NNS	I-NP	O
full	full	JJ	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
upper	upper	JJ	I-NP	O
air	air	NN	I-NP	O
way	way	NN	I-NP	O
symptoms	symptom	NNS	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
tracheostomy	tracheostomy	NN	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O
.	.	.	O	O

ELEVATED	ELEVATED	JJ	B-NP	O
HCT	HCT	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
HCT	HCT	NN	B-NP	B-protein
was	be	VBD	B-VP	I-protein
59	59	CD	B-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
baselin	baselin	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
low	low	JJ	B-ADJP	O
40	40	CD	B-NP	O
's	's	POS	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Part	Part	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
elevation	elevation	NN	I-NP	O
was	be	VBD	B-VP	O
attributed	attribute	VBN	I-VP	O
to	to	TO	B-PP	O
intravascular	intravascular	JJ	B-NP	O
volume	volume	NN	I-NP	O
depletion	depletion	NN	I-NP	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
for	for	IN	B-PP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	I-NP	O
HCT	HCT	NN	I-NP	O
was	be	VBD	B-VP	O
42	42	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
prior	prior	JJ	I-NP	O
documented	document	VBN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
polycythemia	polycythemia	NN	B-NP	O
.	.	.	O	O

Please	Please	VB	B-INTJ	O
consider	consider	VB	B-VP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
erythrocytosis	erythrocytosis	NN	I-NP	O
.	.	.	O	O
.	.	.	O	O

AFib	AFib	NN	B-NP	O
:	:	:	O	O
continued	continue	VBN	B-VP	O
on	on	IN	B-PP	O
digoxin	digoxin	NN	B-NP	O
and	and	CC	I-NP	O
atenolol	atenolol	NN	I-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
rate	rate	NN	I-NP	O
control	control	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
HR	HR	NN	I-NP	O
70-80s	70-80	NNS	I-NP	O
throughout	throughout	IN	B-PP	O
hospital	hospital	NN	B-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

CODE	CODE	NN	B-NP	O
:	:	:	O	O
Discussed	Discuss	VBN	B-VP	O
with	with	IN	B-PP	O
patient	patient	NN	B-NP	O
.	.	.	O	O

FULL	FULL	NN	B-NP	O
CODE	CODE	NN	I-NP	O
.	.	.	O	O

Daughter	Daughter	NN	B-NP	O
hcp	hcp	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
You	You	PRP	B-NP	O
were	be	VBD	B-VP	O
hospitalized	hospitalize	VBN	I-VP	O
for	for	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
condition	condition	NN	I-NP	O
of	of	IN	B-PP	O
hereditary	hereditary	JJ	B-NP	O
angioedema	angioedema	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
FFP	FFP	NN	B-NP	B-protein
with	with	IN	B-PP	O
benadryl	benadryl	NN	B-NP	O
and	and	CC	I-NP	O
pepcid	pepcid	NN	I-NP	O
premedication	premedication	NN	I-NP	O
.	.	.	O	O
.	.	.	O	O

MEDICATION	MEDICATION	NNP	B-NP	O
CHANGES	CHANGES	NNP	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
continue	continue	VB	B-VP	O
all	all	DT	B-NP	O
medications	medication	NNS	I-NP	O
that	that	IN	B-NP	O
you	you	PRP	B-NP	O
were	be	VBD	B-VP	O
on	on	IN	B-PP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
changes	change	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
follow	follow	VBP	B-VP	O
the	the	DT	B-NP	O
stanozolol	stanozolol	NN	I-NP	O
taper	taper	NN	I-NP	O
as	as	IN	B-SBAR	O
outlined	outline	VBN	B-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Gehlert	Gehlert	NNP	I-NP	O
and	and	CC	O	O
colleagues	colleague	NNS	B-NP	O
during	during	IN	B-PP	O
your	your	PRP$	B-NP	O
stay	stay	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
8	8	CD	I-NP	O
hours	hour	NNS	I-NP	O
for	for	IN	B-PP	O
5/23/07	5/23/07	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
2	2	CD	B-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
12	12	CD	I-NP	O
hours	hour	NNS	I-NP	O
for	for	IN	B-PP	O
10/28/07	10/28/07	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
2	2	CD	B-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
day	day	NN	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
then	then	RB	O	O
2	2	CD	B-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Then	Then	RB	B-ADVP	O
you	you	PRP	B-NP	O
should	should	MD	B-VP	O
adjust	adjust	VB	I-VP	O
further	further	RBR	B-ADVP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
in	in	IN	B-PP	O
consultation	consultation	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Bennes	Bennes	NNP	I-NP	O
.	.	.	O	O
.	.	.	O	O

Followup	Followup	NN	B-NP	O
:	:	:	O	O
schedule	schedule	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Areizaga	Areizaga	NNP	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	O
contact	contact	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Demski	Demski	NNP	I-NP	O
to	to	TO	B-VP	O
discuss	discuss	VB	I-VP	O
how	how	WRB	B-ADVP	O
you	you	PRP	B-NP	O
are	be	VBP	B-VP	O
doing	do	VBG	I-VP	O
.	.	.	O	O
.	.	.	O	O

CONTACT	CONTACT	NNP	B-NP	O
YOUR	YOUR	NNP	I-NP	O
DOCTOR	DOCTOR	NNP	I-NP	O
OR	OR	NNP	I-NP	O
RETURN	RETURN	NNP	I-NP	O
TO	TO	NNP	I-NP	O
EMERGENCY	EMERGENCY	NNP	I-NP	O
DEPT.	DEPT.	NNP	I-NP	O
.	.	.	O	O

IF	IF	NN	B-NP	B-protein
:	:	:	O	O
Your	Your	PRP$	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
worsens	worsen	NNS	I-NP	O
,	,	,	O	O
you	you	PRP	B-NP	O
become	become	VBP	B-VP	O
more	more	RBR	B-ADJP	O
bloated	bloat	VBN	B-VP	O
or	or	CC	I-VP	O
distended	distend	VBN	I-VP	O
,	,	,	O	O
you	you	PRP	B-NP	O
develop	develop	VBP	B-VP	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomit	VBG	B-VP	O
,	,	,	O	O
facial	facial	JJ	B-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
difficulty	difficulty	NN	B-NP	O
breathing	breathing	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
concerns	concern	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Consider	Consider	VB	B-VP	O
w/u	w/u	NN	B-NP	O
for	for	IN	B-PP	O
primary	primary	JJ	B-NP	O
for	for	IN	B-PP	O
secondary	secondary	JJ	B-NP	B-protein
polycythemia	polycythemia	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

Stanozolol	Stanozolol	NN	B-NP	O
taper	taper	NN	I-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
PIERMARINI	PIERMARINI	NNP	B-NP	O
,	,	,	O	O
GRADY	GRADY	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DQ060	DQ060	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2/25/07	2/25/07	CD	I-NP	O
@	@	SYM	O	O
01	01	CD	B-NP	O
:	:	SYM	I-NP	O
20	20	CD	I-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

